Atlas Trials

Safety and Efficacy of NRT6008 Administered in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Carcinoma (LAPC)

Clinical trial NCT07555587 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07555587
Sponsor
NRT MedTech Australia Pty Ltd
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Unresectable Locally Advanced Pancreatic Carcinoma
Start date
2026-09-01
Primary completion
2028-08-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.